# Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults

> **NCT02062281** · PHASE4 · COMPLETED · sponsor: **Jiangsu Province Centers for Disease Control and Prevention** · enrollment: 2225 (actual)

## Conditions studied

- Pneumococcal Infection
- Influenza

## Interventions

- **BIOLOGICAL:** 23-valent pneumococcal polysaccharide vaccine
- **BIOLOGICAL:** trivalent influenza vaccine
- **BIOLOGICAL:** 23vPPV+TIV

## Key facts

- **NCT ID:** NCT02062281
- **Lead sponsor:** Jiangsu Province Centers for Disease Control and Prevention
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2013-12
- **Final completion:** 2014-01
- **Target enrollment:** 2225 (ACTUAL)
- **Last updated:** 2014-02-13

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02062281

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02062281, "Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02062281. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*